Article ; Online: The Feasibility of Early Alzheimer's Disease Diagnosis Using a Neural Network Hybrid Platform.
2022 Volume 12, Issue 9
Abstract: Early diagnosis of Alzheimer's Disease (AD) is critical for disease prevention and cure. However, currently, techniques with the required high sensitivity and specificity are lacking. Recently, with the advances and increased accessibility of data ... ...
Abstract | Early diagnosis of Alzheimer's Disease (AD) is critical for disease prevention and cure. However, currently, techniques with the required high sensitivity and specificity are lacking. Recently, with the advances and increased accessibility of data analysis tools, such as machine learning, research efforts have increasingly focused on using these computational methods to solve this challenge. Here, we demonstrate a convolutional neural network (CNN)-based AD diagnosis approach using the surface-enhanced Raman spectroscopy (SERS) fingerprints of human cerebrospinal fluid (CSF). SERS and CNN were combined for biomarker detection to analyze disease-associated biochemical changes in the CSF. We achieved very high reproducibility in double-blind experiments for testing the feasibility of our system on human samples. We achieved an overall accuracy of 92% (100% for normal individuals and 88.9% for AD individuals) based on the clinical diagnosis. Further, we observed an excellent correlation coefficient between our test score and the Clinical Dementia Rating (CDR) score. Our findings offer a substantial indication of the feasibility of detecting AD biomarkers using the innovative combination of SERS and machine learning. We are hoping that this will serve as an incentive for future research in the field. |
---|---|
MeSH term(s) | Alzheimer Disease/diagnosis ; Biomarkers ; Early Diagnosis ; Feasibility Studies ; Humans ; Neural Networks, Computer ; Reproducibility of Results |
Chemical Substances | Biomarkers |
Language | English |
Publishing date | 2022-09-13 |
Publishing country | Switzerland |
Document type | Journal Article ; Randomized Controlled Trial |
ZDB-ID | 2662125-3 |
ISSN | 2079-6374 ; 2079-6374 |
ISSN (online) | 2079-6374 |
ISSN | 2079-6374 |
DOI | 10.3390/bios12090753 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.